Journal Information
Statistics
Follow this link to access the full text of the article
Correspondence
Secondary adrenal insufficiency due to ipilimumab/nivolumab treatment for metastatic renal cancer
Insuficiencia suprarrenal secundaria debida al tratamiento con ipilimumab/nivolumab por cáncer renal metastásico